A CLINICAL TRIAL TO COMPARE EFFICACY AND TOLERABILITY OF ATORVASTATIN IN ADDITION TO ENDOCRINE TREATMENT WITH FOCUS ON MECHANISMS OF RESISTANCE TO ENDOCRINE TREATMENT (FULVESTRANT/AROMATASE INHIBITORS) IN PATIENTS WITH ADVANCED BREAST CANCER: